Produkty 147508-44-9

CAS 147508-44-9 występuje w naszej ofercie pod nazwami: Nomegestrol Impurity 1, 17alpha-Acetoxy-6-hydroxymethyl-3,20-dioxo-19-nor-pregna-4,6-diene. Oferty producentów: Chemat Brand, TRC. Dostępne opakowania: on request, 50mg.

Nomegestrol Impurity 1
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
17alpha-Acetoxy-6-hydroxymethyl-3,20-dioxo-19-nor-pregna-4,6-diene
TRC
  • opakowanie: 50mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(8S,9S,10R,13S,14S,17R)-17-acetyl-6-(hydroxymethyl)-13-methyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate (CAS 147508-44-9) to związek chemiczny o wzorze sumarycznym C23H30O5 i masie molowej 386.5 g/mol. Nazwa systematyczna IUPAC: [(8S,9S,10R,13S,14S,17R)-17-acetyl-6-(hydroxymethyl)-13-methyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate. InChIKey: ZYBJYPZVKRMJHY-YQLZSBIMSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H30O5
Masa molowa386.5 g/mol
Nazwa IUPAC[(8S,9S,10R,13S,14S,17R)-17-acetyl-6-(hydroxymethyl)-13-methyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate
InChIKeyZYBJYPZVKRMJHY-YQLZSBIMSA-N
SMILESCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@H]34)CO)C)OC(=O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 17alpha-Acetoxy-6-hydroxymethyl-3,20-dioxo-19-nor-pregna-4,6-diene, Nomegestrol acetate 6-hydroxy impurity, Nomegestrol acetate 6-hydroxy metabolite, 19-Norpregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-(hydroxymethyl)-
Izomery (ten sam wzór sumaryczny)
(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid C23H30O5
9a-methyl-3-octanoyl-6-[(E)-prop-1-enyl]-3,3a,4,8-tetrahydrofuro[3,2-g]isochromene-2,9-dione C23H30O5
[2-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O5
(1S,2S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,8,13,15-tetramethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C23H30O5
[2-[(8S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O5
[(8S,9S,10R,11S,13S,14S,16R)-11-hydroxy-10,13-dimethyl-3,17-dioxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-16-yl] butanoate C23H30O5
[2-[(8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O5
[(8R,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] acetate C23H30O5
[2-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O5
[2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H30O5
[(6S,8R,9S,13S,14S,17S)-3-acetyloxy-6-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] acetate C23H30O5